🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study was to evaluate the reactogenicity, safety and im...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-02-02
Trial ID
NCT05169905
Treatments Being Tested
The purpose of this study is to assess the safety, reactogenicity and immun...
Status
Withdrawn
Location
GSK Investigational Site
Start Date
2017-07-11
Trial ID
NCT03191383
Substudy A: The study aims to learn about the safety and effects of two new...
Status
Completed
Location
Hospital Militar Central Cirujano Mayor Dr. Cosme Argerich
Start Date
2023-03-09
Trial ID
NCT05788237
The primary objective of this study is to evaluate the immunogenicity and s...
Status
Active Not Recruiting
Location
Baise Center For Disease Control & Prevention
Start Date
2025-09-15
Trial ID
NCT07289542
The primary goal of this study is to evaluate the safety and reactogenicity...
Status
Completed
Location
Accel Research Sites
Start Date
2022-10-14
Trial ID
NCT05585632
Treatments Being Tested
The purpose of this study is to provide critical information on the safety,...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-04-08
Trial ID
NCT03636906
Treatments Being Tested
The primary objectives of the study were: * To assess the safety profile o...
Status
Completed
Location
Matrix Clinical Research-Site Number:8400012
Start Date
2020-09-17
Trial ID
NCT04491877
Treatments Being Tested
The purpose of this study is to evaluate the safety and immunogenicity of d...
Status
Completed
Location
Site # 0361003
Start Date
2025-07-14
Trial ID
NCT07071558
The study will evaluate the safety, tolerability, and immunogenicity of 2 d...
Status
Active Not Recruiting
Location
Hunan Provincial Center for Disease Control and Prevention
Start Date
2025-08-13
Trial ID
NCT07128121
Treatments Being Tested
The main purpose of this study is to evaluate the safety and immunogenicity...
Status
Completed
Location
CenExcel RCA
Start Date
2022-09-21
Trial ID
NCT05664334